Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial.

Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial. J Clin Oncol. 2022 03 01; 40(7):710-718.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung
Exons
Female
Follow-Up Studies
Humans
Lung Neoplasms
Male
Middle Aged
Mutagenesis, Insertional
Prognosis
Quinazolines
Receptor, ErbB-2
Salvage Therapy
Survival Rate

authors with profiles

Marina Chiara Garassino